Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)
Clinical trial NCT01184898 · COMPLETED
Trial details
- NCT number
- NCT01184898
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2012-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.